The Health Roundtable offers corporate organisations the opportunity to participate in its activities to learn more about the issues facing major teaching hospitals.

In return, corporate sponsors are given the opportunity to participate in meetings where there is no direct conflict of interest, and have agreed to abide by the Health Roundtable Honour Code to protect the confidentiality of all Health Roundtable discussions. 

The Health Roundtable welcomes appropriate participation in its discussions of key issues by health industry vendors. Sponsorship is open to organisations involved in the healthcare industry.

We have three levels of support which provide access to our meetings, publications and website.

An application for sponsorship can be found by clicking this link.

For additional information, please contact the General Manager of The Health Roundtable at

AstraZeneca Australia is the ninth largest pharmaceutical company operating in Australia. It is one of the country’s largest manufacturers of medicines and is a key exporter to 20 international markets.

AstraZeneca produces medicines in a range of therapeutic areas including Oncology, Cardiovascular & Metabolic Diseases and Respiratory.

AstraZeneca contributes significantly to clinical trials in Australia with over 55 concurrent trials. AstraZeneca’s innovative medicines are used by millions of patients worldwide. For more information visit
Novartis is caring and curing. Novartis is committed to research and development and since 2007 Novartis has invested 20% of its net pharmaceutical sales globally in R&D – in Australia Novartis invest around $AUD 30 million annually.

Novartis dedication to research drives innovation and has one of the strongest pipelines in the industry. In Australia, the Novartis Group is comprised of – Pharmaceuticals, Alcon, Sandoz, Consumer Health, Animal Health and Vaccines & Diagnostics. To find out more visit
Roche Products Pty Limited, the Australian pharmaceutical division of the international Roche Group, has been committed to improving the health and wellbeing of people in Australia for over 60 years. Today, the company is dedicated to the clinical development, registration, sales, marketing and distribution of innovative pharmaceutical medicines.

Over the last two decades, Roche has become a leading specialist in biotechnology focused on developing medicines in oncology (cancer), immunology, ophthalmology, infectious diseases, and neuroscience.

Australian patients have access to around 40 Roche medicines, and the company is the leading provider of cancer medicines in Australia by sales.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anaesthetics; and pharmacy automation, software, and services.

Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.


Sydney Office

Level 2
120 Chalmers Street
Surry Hills, NSW 2010

Call Us

In Australia: +61 (02) 8041 1421

In New Zealand: +64 3741 3123

© 1995-2019 The Health Roundtable   

Partners and Members